OrbiMed’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-764,600	Closed	-$11.8M	–	119
2024 Q3	$11.8M	Buy	+764,600	New	+$12.8M	0.22%	76
2021 Q1	–	Sell	-265,772	Closed	-$14.2M	–	159
2020 Q4	$14.2M	Buy	265,772 +158,772	+148%	+$7.88M	0.12%	115
2020 Q3	$4.41M	Buy	+107,000	New	+$4.62M	0.06%	129
2020 Q1	–	Sell	-96,143	Closed	-$4.11M	–	144
2019 Q4	$4.11M	Hold	96,143	–	–	0.06%	107
2019 Q3	$3.46M	Sell	96,143 -5,757	-6%	-$175K	0.07%	101
2019 Q2	$2.72M	Buy	+101,900	New	+$2.6M	0.04%	119
2018 Q3	–	Sell	-4,282,400	Closed	-$65.4M	–	151
2018 Q2	$65.4M	Buy	4,282,400 +941,700	+28%	+$16.8M	0.79%	42
2018 Q1	$75.1M	Buy	3,340,700 +2,491,600	+293%	+$69M	0.94%	37
2017 Q4	$25.6M	Buy	+849,100	New	+$27.2M	0.32%	71
2017 Q2	–	Sell	-1,169,000	Closed	-$40.2M	–	139
2017 Q1	$40.2M	Buy	+1,169,000	New	+$41.3M	0.46%	57
2016 Q2	–	Sell	-1,401,600	Closed	-$39.2M	–	138
2016 Q1	$39.2M	Buy	+1,401,600	New	+$30.6M	0.41%	55
2014 Q1	–	Sell	-135,000	Closed	-$3.37M	–	141
2013 Q4	$3.37M	Sell	135,000 -177,000	-57%	-$4.18M	0.05%	106
2013 Q3	$8.57M	Sell	312,000 -981,000	-76%	-$20.5M	0.16%	83
2013 Q2	$23.5M	Buy	+1,293,000	New	+$17.8M	0.53%	42